Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone
Drug - Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone
The trade name of the product as shown on the labeling.
Dosage -
OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Bacitracin Zinc; Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.
Strength -
400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM
The potency of the active ingredient(s), Bacitracin Zinc; Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate. May repeat for multiple part products.
Applicant -
PHARMAFAIR
The firm name holding legal responsibility for Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
062381
The FDA assigned number to Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Sep 6, 1985
The date Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Pharmafair Inc
The full name of the firm holding legal responsibility for the new application of Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone.
Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone
Zinc Bacitracin,neomycin Sulfate,polymyxin B Sulfate & Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Cortisporin 400 Units/gm;1%;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Topical Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;5,000 Units/gm Ointment; Topical Bacitracin 500 Units/gm Ointment; Topical Baci-rx 5,000,000 Units/bot Powder; For Rx Compounding Bacitracin 5,000,000 Units/bot Powder; For Rx Compounding Bacitracin 5,000,000 Units/bot Powder; For Rx Compounding Ziba-rx 500,000 Units/bot Powder; For Rx Compounding Cortisporin 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone 400 Units/gm;1%;eq 3.5mg Base/gm;10,000 Units/gm Ointment; Ophthalmic
NewDrugInformation
|
